Not finding it? Sign in to also search OpenAlex live.
-
Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG)
A. M. de Jong, A. van der Boog, C. C. B. Post, Fia Cialdella, Daniëlle B. P. Eekers, J. Hendrikse, +13 more
0citations -
Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting
Mark P. van Opijnen, Marike L. D. Broekman, Edwin P. J. G. Cuppen, Hendrikus Jan Dubbink, Arja ter Elst, Ronald van Eijk, +9 more
5citations -
Retraction Note: Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients2024 Quality of Life Research retraction Medicine Cancer-related cognitive impairment studies Open access
Ivan Caramanna, Martin Klein, Martin J. van den Bent, Ahmed Idbaïh, Wolfgang Wick, MARTIN J.B. TAPHOORN, +3 more
0citations -
Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials2023 European Journal of Cancer article Medicine Cancer-related cognitive impairment studies Open access
Ivan Caramanna, Jaap C. Reijneveld, Peter Marinus van de Ven, Martin J. van den Bent, Ahmed Idbaïh, Wolfgang Wick, +4 more
12citations -
PL01.5.A ASSOCIATION BETWEEN RESTING-STATE-NETWORK FUNCTIONAL CONNECTIVITY AND SURVIVAL IN RECURRENT GLIOMAS DIAGNOSED USING FET PET2024 Neuro-Oncology conference-abstract Neuroscience Functional Brain Connectivity Studies Open access
Michel Friedrich, Jan‐Michael Werner, Jörg Steinbach, Michael Sabel, Ulrich Herrlinger, Marc Dieter Piroth, +10 more
0citations -
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target
Rosa Luning, Sybren L. N. Maas, Pim J. French, Youri Hoogstrate, Levi van Hijfte, Rania Head, +4 more
0citations -
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by O-(2-[18F]fluoroethyl)- l -tyrosine PET
Michel Friedrich, Jan‐Michael Werner, Jörg Steinbach, Michael Sabel, Ulrich Herrlinger, Marc Dieter Piroth, +11 more
4citations -
Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity2025 Molecular Therapy article Medicine Glioma Diagnosis and Treatment Open access cited by 1 patent
Taral R. Lunavat, Lisa Nieland, Sanne M. van de Looij, Alexandra J E M de Reus, Charles Couturier, Chadi A. El Farran, +18 more
6citations -
Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes2020 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Glioma Diagnosis and Treatment Open access
Eike Steidl, Karl‐Josef Langen, Sarah Abu Hmeidan, Nenad Polomac, Christian Filß, Norbert Galldiks, +8 more
57citations -
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)
Jaap C. Reijneveld, Abigirl Machingura, Corneel Coens, MARTIN J.B. TAPHOORN, Walter Taal, Paul M. Clément, +10 more
13citations